Table 11.6i
Immunosuppression Use for Antirejection Treatment from Transplant
to One Year Following Transplantation, 1996 to 2005
Recipients with Heart Transplants
| 2,343 |
2,293 |
2,348 |
2,188 |
2,199 |
2,202 |
2,155 |
2,057 |
2,015 |
2,125 |
| 854 |
871 |
979 |
916 |
901 |
849 |
803 |
657 |
534 |
532 |
| 18.1% |
19.3% |
21.2% |
17.7% |
16.3% |
15.5% |
17.4% |
18.4% |
15.5% |
18.2% |
| 5.4% |
7.9% |
7.3% |
6.3% |
4.6% |
3.9% |
4.0% |
4.6% |
2.6% |
2.4% |
| 13.9% |
13.1% |
14.9% |
7.4% |
5.1% |
5.8% |
6.8% |
4.1% |
3.2% |
3.4% |
| 0.0% |
0.1% |
0.2% |
2.0% |
3.8% |
4.9% |
6.4% |
7.5% |
8.6% |
9.6% |
| 0.0% |
0.1% |
0.8% |
2.5% |
3.0% |
2.5% |
1.5% |
2.0% |
1.5% |
3.6% |
| 0.0% |
0.0% |
0.1% |
0.9% |
2.0% |
0.4% |
0.4% |
1.4% |
0.6% |
0.8% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.2% |
0.2% |
| 88.3% |
88.6% |
87.9% |
91.3% |
92.3% |
92.7% |
92.2% |
92.5% |
91.4% |
90.8% |
| 88.3% |
88.6% |
87.9% |
91.3% |
92.3% |
92.7% |
92.2% |
92.5% |
91.4% |
90.8% |
| 5.4% |
7.6% |
6.5% |
4.6% |
4.4% |
2.0% |
3.0% |
3.5% |
1.7% |
2.3% |
| 1.8% |
3.6% |
2.5% |
2.1% |
1.7% |
0.5% |
0.9% |
1.7% |
1.3% |
1.3% |
| 3.6% |
4.1% |
4.3% |
2.6% |
2.8% |
1.5% |
2.1% |
1.8% |
0.4% |
0.9% |